Elevation Oncology Stock Price on December 20, 2024
| ELEV Stock | USD 0.56 0.01 1.75% |
If you're considering investing in Elevation Stock, it is important to understand the factors that can impact its price. As of today, the current price of Elevation Oncology stands at 0.56, as last reported on the 25th of December, with the highest price reaching 0.59 and the lowest price hitting 0.55 during the day. At this stage we consider Elevation Stock to be dangerous. Elevation Oncology secures Sharpe Ratio (or Efficiency) of 0.0152, which denotes the company had a 0.0152% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Elevation Oncology, which you can use to evaluate the volatility of the firm. Please confirm Elevation Oncology's Mean Deviation of 3.98, coefficient of variation of 6710.64, and Downside Deviation of 5.71 to check if the risk estimate we provide is consistent with the expected return of 0.08%.
At this time, Elevation Oncology's Liabilities And Stockholders Equity is fairly stable compared to the past year. Other Stockholder Equity is likely to climb to about 263.3 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 28.2 M in 2024. . At this time, Elevation Oncology's Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to climb to 0.01 in 2024, whereas Price To Operating Cash Flows Ratio is likely to drop (0.34) in 2024. Elevation Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Elevation |
Sharpe Ratio = 0.0152
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | ELEV | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.27 actual daily | 46 54% of assets are more volatile |
Expected Return
| 0.08 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Elevation Oncology is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Elevation Oncology by adding it to a well-diversified portfolio.
Price Book 0.4889 | Book Value 1.173 | Enterprise Value -38.1 M | Enterprise Value Ebitda (3.08) | Shares Float 41.1 M |
Elevation Oncology Main Headline on 20th of December 2024
Elevation Oncology Given Market Outperform Rating at JMP Sec... by thelincolnianonline.com
JMP Securities reiterated their market outperform rating on shares of Elevation Oncology in a research report report published on Thursday morning,Benzinga reports. They currently have a 7.00 target price on the stock. Several other brokerages also recently weighed in on ELEV. Stephens reiterated an overweight rating and set a 5.00 price
Elevation Oncology Valuation on December 20, 2024
It is possible to determine the worth of Elevation Oncology on a given historical date. On December 20, 2024 Elevation was worth 0.62 at the beginning of the trading date compared to the closed value of 0.58. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Elevation Oncology stock. Still, in general, we apply an absolute valuation method to find Elevation Oncology's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Elevation Oncology where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Elevation Oncology's related companies.
| Open | High | Low | Close | Volume | |
| 0.63 | 0.67 | 0.61 | 0.63 | 731,831 | |
12/20/2024 | 0.62 | 0.66 | 0.55 | 0.58 | 2,489,251 |
| 0.59 | 0.59 | 0.55 | 0.57 | 1,341,226 |
| Backtest Elevation Oncology | | | Elevation Oncology History | | | Elevation Oncology Valuation | Previous | Next |
Elevation Oncology Trading Date Momentum on December 20, 2024
| On December 23 2024 Elevation Oncology was traded for 0.57 at the closing time. The top price for the day was 0.59 and the lowest listed price was 0.55 . The trading volume for the day was 1.3 M. The trading history from December 23, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 1.72% . The overall trading delta against the current closing price is 0.00% . |
Elevation Oncology Fundamentals Correlations and Trends
By evaluating Elevation Oncology's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Elevation Oncology's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Elevation financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Elevation Oncology Stock history
Elevation Oncology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Elevation is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Elevation Oncology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Elevation Oncology stock prices may prove useful in developing a viable investing in Elevation Oncology
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 34.1 M | 28.2 M | |
| Net Loss | -85.6 M | -81.3 M |
Elevation Oncology Quarterly Net Working Capital |
|
Elevation Oncology Stock Technical Analysis
Elevation Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Elevation Oncology Period Price Range
Low | December 25, 2024
| High |
0.00 | 0.00 |
Elevation Oncology cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Elevation Oncology December 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Elevation Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Elevation Oncology shares will generate the highest return on investment. By undertsting and applying Elevation Oncology stock market strength indicators, traders can identify Elevation Oncology entry and exit signals to maximize returns
Elevation Oncology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Elevation Oncology's price direction in advance. Along with the technical and fundamental analysis of Elevation Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Elevation to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0204 | |||
| Jensen Alpha | 0.0209 | |||
| Total Risk Alpha | (0.16) | |||
| Sortino Ratio | 0.0056 | |||
| Treynor Ratio | 0.0506 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Elevation Stock Analysis
When running Elevation Oncology's price analysis, check to measure Elevation Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevation Oncology is operating at the current time. Most of Elevation Oncology's value examination focuses on studying past and present price action to predict the probability of Elevation Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevation Oncology's price. Additionally, you may evaluate how the addition of Elevation Oncology to your portfolios can decrease your overall portfolio volatility.